Document is current
Any future updates will be listed below
-
Authors
Ito, Yoshito
Kawamura, Masashi
Kawamura, Takuji
Tamai, Katsuto
Yoshioka, Daisuke
Matsuura, Ryohei
Kawamura, Ai
Misumi, Yusuke
Harada, Akima
Watabe, Tadashi
Goto, Takasumi
Yamada, Atsushi
Ogita, Hisakazu
Taira, Masaki
Shimamura, Kazuo
Miyagawa, Shigeru
-
Funding
Funding for this research was provided by:
StemRIM Inc.
- License Information
-
More Information
Article History
Received: 24 September 2024
Accepted: 30 January 2026
First Online: 11 February 2026
Declarations
:
: This research was funded by the StemRIM Inc. (Osaka, Japan). StemRIM Inc. may benefit from the clinical development of HMGB1 fragment; however, the company had no involvement in the conduct or reporting of this study. Katsuto Tamai was a founder and stockholder of StemRIM Inc. The other authors declare no conflicts of interest.
